Edward Jones has upgraded CVS Health (NYSE:CVS) to buy from hold, citing a potential turnaround in its Aetna insurance business. The investment firm said it believes CVS (NYSE:CVS) will improve ...
On Thursday, Edward Jones, a financial services firm, upgraded CVS Health (NYSE:CVS) stock from Hold to Buy. The upgrade comes as the stock, which InvestingPro analysis shows is currently ...
Meanwhile, Edward Jones analyst Ashtyn Evans upgraded CVS Health stock to Buy from Hold, as he believes that the company could be an attractive turnaround story, with the potential for the new ...
Edward Jones last night upgraded CVS Health (CVS) to Buy from Hold. The company could be an attractive turnaround story” with the potential for new management improving in its health insurance ...
According to Edward Jones, “CVS has seen health care delivery costs rise as more seniors get procedures done. There also have been changes in the Medicare Advantage program along with CVS's own ...
CVS Health (NYSE:CVS – Free Report) had its target price increased by Wolfe Research from 67.00 to 70.00 in a report ...
CVS Health (NYSE:CVS – Free Report) had its price objective decreased by UBS Group from $62.00 to $59.00 in a research note ...
Edward Jones upgraded CVS Health (CVS) to Buy from Hold. The company could be an attractive turnaround story" with the potential for new management improving in its health insurance division ...